Addition of montelukast versus double dose of inhaled budesonide in moderate persistent asthma

YILDIRIM Z., Ozlu T., BULBUL Y., BAYRAM H.

RESPIROLOGY, vol.9, no.2, pp.243-248, 2004 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 9 Issue: 2
  • Publication Date: 2004
  • Doi Number: 10.1111/j.1440-1843.2004.00555.x
  • Journal Name: RESPIROLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.243-248
  • Karadeniz Technical University Affiliated: Yes

Abstract

Background: Although current guidelines suggest the use of inhaled corticosteroids as the first line therapy in persistent asthma, the concerns about high-dose corticosteroids may limit their usage. We aimed to investigate the efficacy of inhaled budesonide plus oral montelukast versus a double dose of inhaled budesonide.